Firefly Neuroscience (AIFF) Net Asset Value

Public company logo of Firefly Neuroscience (AIFF)

Firefly Neuroscience, Inc (AIFF) relies on a virtual cloud-based EEG analysis infrastructure, which mitigates physical risks and ensures the stability of IT workflows. The specifics of digital neuroscience render the company a defensive asset whose performance is minimally dependent on economic crises. The current indicator is 0.01. The financial price action on GURU.Markets illustrates Firefly Neuroscience, Inc (AIFF), whose success is tied to psychiatry's transition toward objective brain mapping via AI.

AIFF Firefly Neuroscience Book Capitalization (07/04/2022 - 10/28/2026)
Flagship merchandise of Firefly Neuroscience, Inc.

The development of BrainScope requires significant resources; therefore, the balance sheet capitalization of Firefly Neuroscience, Inc (AIFF), which measures the difference between all assets and liabilities, serves as an indicator of capital resilience in the face of operating losses. An analysis of the firm's net balance sheet assets chart allows for the filtering of market noise and an assessment of the real value of assets, revealing the rate of cash burn during periods of slow AI platform implementation in clinics.

Analysis of competing companies

BIIB - Net Asset Value|Book Capitalization Neurocrine Biosciences (NBIX)|RGC (regencellbioscience.com) - Net Asset Value|Company Book Value Axsome Therapeutics, Inc. (AXSM)|Accounting Capitalization ACADIA Pharma|Xenon Pharmaceuticals Inc - Book Capitalization|Total Stockholders' Equity Viking Therapeutics Corp VKTX|Company Net Assets SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Book Capitalization|Company Book Value Denali Therapeutics Inc. (DNLI)|HRMY: Accounting Value of Company|Company Book Value BHVN|Amylyx Corp (AMLX) - Total Stockholders' Equity|Book Capitalization Trevi Therapeutics TRVI|Net Asset Value praxismedicines.com|AVXL (Anavex Life Sciences Corp.) - Book Capitalization|Book Valuation of Business CBLL (CeriBell Inc)|Company Book Value prothena.com|Accounting Value of Company Alector Inc. ALEC|ANNX (Annexon, Inc.) - Book Capitalization|OMER - Total Stockholders' Equity|Book Capitalization Neurogene (NGNE)|ACIU (AC Immune S.A.) - Net Asset Value|Company Book Value Voyager Pharma|Company Book Value Neumora Corp (NMRA)|Scilex Holding Company - Company Net Assets|Total Stockholders' Equity tevogen.com TVGN|Company Net Assets Alpha Cognition Inc.|cogrx.com - Accounting Value of Company|Inhibikase (IKT) - Company Book Value|SAVA - Accounting Capitalization|Book Capitalization ASRT|Total Stockholders' Equity Coya Therapeutics|VTGN (VistaGen Therapeutics, Inc.) - Company Net Assets|Book Capitalization OVID|Acumen Pharma (ABOS) - Company Book Value|Accounting Value of Company CRVO (CervoMed Corporation)|ATHE: Company Book Value|Clene Inc - Total Stockholders' Equity|Company Book Value PEPG (PepGen Corp)|JUNS - Book Valuation of Business|RLMD (Relmada) - Book Capitalization|Annovis Bio Corporation (ANVS) - Company Net Assets|GRCE: Book Capitalization|Book Valuation of Business ANEW Medical, Inc.|NeuroSense Therapeutics - Book Capitalization|Total Stockholders' Equity RVPH (Reviva Pharmaceuticals Holdings Inc.)|MTVA - Company Book Value|Accounting Capitalization NeurAxis Inc NRXS|HSDT: Book Capitalization|PASG - Company Net Assets|Book Capitalization NEUP|Total Stockholders' Equity Minerva Neurosciences Inc|ATHA - Company Net Assets|Accounting Value of Company Addex|ALZN (Alzamend Neuro, Inc.) - Book Capitalization|Book Valuation of Business CYCN (cyclerion.com)|PTIX - Company Book Value|Accounting Capitalization Pasithea Therapeutics Corp KTTA|CRGT: Book Capitalization|ATXI - Company Net Assets|BCLI: Book Capitalization|caratherapeutics.com (CARA) - Book Capitalization|CHRO: Book Capitalization|Book Valuation of Business Eliem|ITCI - Book Capitalization|Net Asset Value Longboard (LBPH)|Marinus Pharmaceuticals (MRNS) - Book Capitalization|nkgenbiotech.com - Net Asset Value|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Book Value|SAGE - Accounting Capitalization|Book Capitalization SNPX|Total Stockholders' Equity Trevena Inc|VIGL (Vigil Neuroscience Inc.) - Company Net Assets|Book Capitalization WENA|Cerevel Therapeutics, Inc. (CERE) - Company Book Value